Evidence map›Paper›PMID 29455554›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2018

Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study.

Walaa M El-Husseiny, Magda A-A El-Sayed, Naglaa I Abdel-Aziz, Adel S El-Azab, Esam R Ahmed, Alaa A-M Abdel-Aziz

Open access · goldAbstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. RSC advances · 2024
    Article
  7. Article
  8. Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed withJournal of enzyme inhibition and medicinal chemistry · 2022
    Article
  9. Synthesis and Evaluation of Some New 4Pharmaceuticals (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Synthesis and Characterization of Some New Quinoxalin-2(Molecules (Basel, Switzerland) · 2021
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Walaa M El-Husseinya Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy , Mansoura University , Mansoura , Egypt.
Magda A-A El-Sayeda Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy , Mansoura University , Mansoura , Egypt.ORCID http://orcid.org/0000-0001-9599-9248
Naglaa I Abdel-Azizc Department of Medicinal Chemistry, Faculty of Pharmacy , Mansoura University , Mansoura , Egypt.
Adel S El-Azabd Department of Pharmaceutical Chemistry, College of Pharmacy , King Saud University , Riyadh , Saudi Arabia.ORCID http://orcid.org/0000-0001-7197-1515
Esam R Ahmedf Confirmatory Diagnostic Unit , Vacsera , Giza , Egypt.
Alaa A-M Abdel-Azizc Department of Medicinal Chemistry, Faculty of Pharmacy , Mansoura University , Mansoura , Egypt.ORCID http://orcid.org/0000-0002-3362-9337
Mansoura University · EGAl-Azhar University · EGDamietta University · EGVacsera (Egypt) · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New α,β-unsaturated ketones 4a,b; 5a-c; and 6a,b; as well as 4-H pyran 7; pyrazoline 8a,b; isoxazoline 9; pyridine 10-11; and quinoline-4-carboxylic acid 12a,b derivatives were synthesized and evaluated for in vitro antitumour activity against HepG2, MCF-7, HeLa, and PC-3 cancer cell lines. Antioxidant activity was investigated by the ability of these compounds to scavenge the 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) radical cation (ABTS

Indexed as

Antineoplastic AgentsAntioxidantsCell Line, TumorCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorErbB ReceptorsHeterocyclic CompoundsHumansKetonesModels, MolecularMolecular StructureProtein Kinase InhibitorsStructure-Activity RelationshipAntineoplastic AgentsAntioxidantsErbB ReceptorsHeterocyclic CompoundsKetonesProtein Kinase Inhibitorsantioxidant effectantitumour activityEGFR inhibitionmolecular dockingα,β-Unsaturated ketone

Identifiers

PMID29455554
PMCPMC6010098
OpenAlexW2790819799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.